:: Volume 3, Issue 3 ( Journal of Clinical and Basic Research (JCBR) 2019) ::
jcbr 2019, 3(3): 33-38 Back to browse issues page
New-Onset Systemic Lupus Erythematosus in a Pregnant Woman: A Case Report
Mohadese Motaharinezhad1 , Fatemeh Torklalebaq2 , Maryam Moradi 1
1- Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
2- Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:   (271 Views)
Background: Systemic lupus erythematosus (SLE) is a multi-systemic inflammatory disease that mainly affects women of childbearing age. Development of SLE during pregnancy increases the risk of some maternal and fetal complications. We herein present a pregnant woman with new-onset SLE during pregnancy.
Case description: A 30-year-old pregnant woman with a gestational age of 30 weeks and twin pregnancy was referred to a hospital because of bradycardia and arrhythmia of fetuses during routine pregnancy checkups. The patient was later diagnosed with SLE and received hydroxychloroquine and dexamethasone. During the course of treatment, the patient developed erythematosus skin lesions and was hospitalized for further evaluations. Various consultations were made. Given the overall conditions of the mother and fetuses, caesarean section was performed at week 34 of pregnancy. Finally, the patient was discharged with good general condition after one month of hospitalization.
Conclusion: Active SLE during pregnancy is associated with an increased risk of maternal and fetal complications. It is essential to consider the impact of pregnancy on the disease, the impact of the disease on fetal health and the safety of medications used during pregnancy and lactation. For improved fetal and maternal outcomes, a multidisciplinary approach comprising of gynecology, neonatology and internal medicine should be taken when treating pregnant women with SLE.
Keywords: Systemic lupus erythematosus, Pregnancy
Full-Text [PDF 217 kb]   (80 Downloads)    
Article Type: Case report | Subject: Medicine
Received: 2019/10/25 | Accepted: 2019/10/25 | Published: 2019/10/25
1. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clinical Journal of the American Society of Nephrology. 2010;5(11):2060-8. [DOI:10.2215/CJN.00240110]
2. Jeremic K, Stefanovic A, Dotlic J, Stojnic J, Kadija S, Vilendecic Z, Janjic T, Jeremic J. Neonatal outcome in pregnant patients with antiphospholipid syndrome. Journal of perinatal medicine. 2015 ;43(6):761-8. [DOI:10.1515/jpm-2014-0118]
3. Stojan G, Baer AN, Hochberg, Chakravarty, Clowse, Chakravarty, Moroni, Smyth, Buyon, Clowse, Huong. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert review of clinical immunology. 2012 ;8(5):439-53. [DOI:10.1586/eci.12.36]
4. Yee CS, Akil M, Khamashta M, Bessant R, Kilding R, Giles I, Farewell VT, Gordon C. The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients. Rheumatology. 2012 ;51(10):1877-80. [DOI:10.1093/rheumatology/kes158]
5. Wu CQ, Kustec VE, Brown RN, Martin MC, Filion KB. The medical management of antiphospholipid syndrome in pregnancy: a meta-analysis. Obstetrics & Gynecology. 2014 ;123:178S-9S. [DOI:10.1097/01.AOG.0000447195.12926.b9]
6. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Annals of the rheumatic diseases. 2017 ;76(3):476-85. [DOI:10.1136/annrheumdis-2016-209770]
7. Nayana DH, Kondareddy T, Kaytri S. SLE during pregnancy, maternal and perinatal outcome in Teritary hospital. Int J Reprod Contracept Obstet Gynecol. 2017;6(2):507-11. [DOI:10.18203/2320-1770.ijrcog20170371]
8. Akbarian M, Rostamian A, editors. Systematic Lupus Erythmatosus. Tehran, Iran: Rheumatology Research Center, Tehran University of Medical Science; 2011. [Persian]
9. Akbarian M, Faezi ST, Gharibdoost F, Shahram F, Nadji A, Jamshidi AR, Akhlaghi M, Shafaie N, Akhlaghkhah M, Davatchi F. Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. International journal of rheumatic diseases. 2010;13(4):374-9. [DOI:10.1111/j.1756-185X.2010.01547.x]
10. Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheumatic Disease Clinics. 2017 ;43(2):215-26. [DOI:10.1016/j.rdc.2016.12.009]
11. Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010;19(14):1665-73. [DOI:10.1177/0961203310378669]
12. Carvalheiras G, Vita P, Marta S, Trovão R, Farinha F, Braga J, Rocha G, Almeida I, Marinho A, Mendonça T, Barbosa P. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clinical reviews in allergy & immunology. 2010;38(2-3):302-6. [DOI:10.1007/s12016-009-8161-y]
13. Ku M, Guo S, Shang W, Li Q, Zeng R, Han M, Ge S, Xu G. Pregnancy outcomes in chinese patients with systemic lupus erythematosus (sle): a retrospective study of 109 pregnancies. PloS one. 2016;11(7):e0159364. [DOI:10.1371/journal.pone.0159364]
14. Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, Nelson-Piercy C. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. The Journal of rheumatology. 2011;38(9):1906-13. [DOI:10.3899/jrheum.100997]
15. Sovio U, White IR, Dacey A, Pasupathy D, Smith GC. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. The Lancet. 2015;386(10008):2089-97. [DOI:10.1016/S0140-6736(15)00131-2]
16. Koh JH, Ko HS, Kwok SK, Ju JH, Park SH. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. Lupus. 2015;24(2):210-7. [DOI:10.1177/0961203314555352]
17. Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. American journal of obstetrics and gynecology. 2013;208(1):64-e1. [DOI:10.1016/j.ajog.2012.09.020]
18. Webster P, Wardle A, Bramham K, Webster L, Nelson-Piercy C, Lightstone L. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2014;23(11):1192-6. [DOI:10.1177/0961203314540353]
19. Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, Da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the rheumatic diseases. 2016;75(5):795-810. [DOI:10.1136/annrheumdis-2015-208840]

XML     Print

Volume 3, Issue 3 ( Journal of Clinical and Basic Research (JCBR) 2019) Back to browse issues page